Biotech Values

[genisi]

From Craig Wheeler’s comments on the GS webcast, a reasonable investor can infer that the sole remaining roadblock to approval of the Lovenox ANDA is the FDA’s assuring the integrity of the Chinese supply of bulk heparin.

Has Wheeler mentioned anything regarding Sanofi's yet to be answered Citizen's Petition at the FDA? (we all assume this is the least difficult barrier before approval of generic Lovenox, but the CP was not denied yet.)